|
PHF3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.2159999985868E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11940001712441E-09 |
| Normal-vs-Stage2 |
4.924400E-03 |
| Normal-vs-Stage3 |
1.266430E-01 |
| Normal-vs-Stage4 |
4.681200E-01 |
| Stage1-vs-Stage2 |
3.997800E-01 |
| Stage1-vs-Stage3 |
1.590470E-02 |
| Stage1-vs-Stage4 |
6.345900E-02 |
| Stage2-vs-Stage3 |
3.086600E-01 |
| Stage2-vs-Stage4 |
3.081400E-01 |
| Stage3-vs-Stage4 |
8.417200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.07690000028526E-07 |
| Normal-vs-AfricanAmerican |
4.21259999999757E-05 |
| Normal-vs-Asian |
1.024550E-03 |
| Caucasian-vs-AfricanAmerican |
8.826000E-01 |
| Caucasian-vs-Asian |
6.805400E-01 |
| AfricanAmerican-vs-Asian |
6.113400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.26270044104638E-10 |
| Normal-vs-Female |
6.548500E-02 |
| Male-vs-Female |
4.002800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.979900E-04 |
| Normal-vs-Extreme_Weight |
1.97889482578262E-11 |
| Normal-vs-Obese |
3.984500E-02 |
| Normal-vs-Extreme_Obese |
5.780800E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.555700E-02 |
| Normal_Weight-vs-Obese |
2.773400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.747200E-01 |
| Extreme_Weight-vs-Obese |
1.897710E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.838000E-01 |
| Obese-vs-Extreme_Obese |
3.235000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.942400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.99259999999324E-05 |
| Normal-vs-Age(61-80Yrs) |
4.57969995260044E-10 |
| Normal-vs-Age(81-100Yrs) |
3.13060000001197E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.858000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.812000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.660100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.599100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.218400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.049000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.12089950841255E-10 |
| Normal-VS-Type2 PRCC |
3.99400000000716E-05 |
| Normal-VS-KIRP CIMP |
2.379800E-01 |
| Normal-VS-Unclassified PRCC |
5.361100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.328000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.518200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.737160E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.326100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.308000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.437800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.03509994914464E-09 |
| Normal-vs-N1 |
3.142000E-01 |
| Normal-vs-N2 |
6.764500E-02 |
| N0-vs-N1 |
8.378400E-04 |
| N0-vs-N2 |
2.772600E-01 |
| N1-vs-N2 |
2.951800E-01 |
|
|
